Public Health

India is reckoned among the global leaders in the manufacturing of generic medicines. But, it is also held that the largest number of populace in India is living without having an access to basic medicines. The World Medicines Situation Report 2004 of the World Health Organization (WHO) pointed out that approximately 67 % of the population lives without an access to essential medicines.

This policy brief urges parliamentarians to seriously consider implementing public health safeguards such as compulsory licensing which authorizes production of generic medicines only in the event of failure on the part of patent holder to comply with the obligations to make patented medicines available and affordable to patients.

The draft pharmaceutical policy (2006) envisages to ensure that there is adequate growth in the Research and Development sector of India and there is easy accessibility of quality drugs at a reasonable price.